Exscientia (EXAI)
NASDAQ: EXAI
· Real-Time Price · USD
4.84
null (null%)
At close: Nov 19, 2024, 9:00 PM
undefined% (1D)
Bid | n/a |
Market Cap | 633.18M |
Revenue (ttm) | 17.07M |
Net Income (ttm) | -150.51M |
EPS (ttm) | -1.51 |
PE Ratio (ttm) | -3.205298013245033 |
Forward PE | n/a |
Analyst | Hold |
Ask | n/a |
Volume | 0 |
Avg. Volume (20D) | 0 |
Open | undefined |
Previous Close | undefined |
Day's Range | 4.84 - 4.84 |
52-Week Range | 4.84 - 4.84 |
Beta | 0.83 |
About EXAI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EXAI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EXAI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Exscientia is scheduled to release its earnings on May 2, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 year ago
Exscientia shares are trading lower after the comp...
Unlock content with
Pro Subscription

7 months ago · businesswire.com
Exscientia Achieves Milestones for Two Programmes in Sanofi CollaborationOXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) today announced the advancement of two additional discovery programmes within its collaboration with Sanofi, with Exscientia receiving a...

9 months ago · businesswire.com
Exscientia Business Update for Second Quarter and First Half 2024OXFORD, U.K.--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI): Recent advancements in the Company's pipeline, collaborations and operations, as well as financial results for the second quarter and firs...